Masonic Children's Hospital/University of Minnesota — Minneapolis, Minnesota

Masonic Children's Hospital/University of Minnesota is a clinical research site located in Minneapolis, Minnesota, United States 55454.

Crixeo Clinical Trials Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Masonic Children's Hospital/University of Minnesota has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Medulloblastoma, Central Nervous System Embryonal Tumors.

Sponsors: Parth Patel.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Minneapolis

Browse all research sites in Minnesota · View every site in Minneapolis

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Masonic Children's Hospital/University of Minnesota?

Masonic Children's Hospital/University of Minnesota has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Masonic Children's Hospital/University of Minnesota conducted?

Masonic Children's Hospital/University of Minnesota has 1 clinical trials on record, with 1 currently active. Their work covers Medulloblastoma, Central Nervous System Embryonal Tumors.

Is Masonic Children's Hospital/University of Minnesota accredited by Crixeo Clinical Trials?

Masonic Children's Hospital/University of Minnesota has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Masonic Children's Hospital/University of Minnesota?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.